{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:10:49Z","timestamp":1777997449982,"version":"3.51.4"},"reference-count":140,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CMAR"],"DOI":"10.2147\/cmar.s604924","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:10:13Z","timestamp":1777993813000},"page":"1-26","source":"Crossref","is-referenced-by-count":0,"title":["Customized Marketing Strategies for Cancer Immunocyte Therapy Based on its Distinctive Attributes"],"prefix":"10.2147","volume":"Volume 18","author":[{"given":"Xiaojing","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinbin","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,5]]},"reference":[{"key":"ref1","unstructured":"Organization WH. Global cancer burden growing, amidst mounting need for services. Available from: https:\/\/www.who.int\/news\/item\/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services. Accessed May 01, 2026."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.7826","volume":"9","author":"Simiao","year":"2023","journal-title":"JAMA Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-023-08809-3","volume":"50","author":"Rasanpreet","year":"2023","journal-title":"Mol Biol Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103627","volume":"172","author":"Emiliano","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003777","volume":"10","author":"Oaknin","year":"2022","journal-title":"J ImmunoTher Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2025.03.005","author":"Patel","year":"2025","journal-title":"Mol ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3892\/or.2024.8744","volume":"51","author":"Yu","year":"2024","journal-title":"Oncol Rep"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduction Targeted Ther"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s12672-025-02198-8","volume":"16","author":"Zafar","year":"2025","journal-title":"Discov Oncol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3390\/cancers17050821","volume":"17","author":"Bandara","year":"2025","journal-title":"Cancers"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41587-025-02625-9","volume":"43","author":"Marchal","year":"2025","journal-title":"Nature Biotechnol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta21070","volume":"21","author":"Hettle","year":"2017","journal-title":"Health Technol Assess"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"802210","DOI":"10.3389\/fonc.2022.802210","volume":"12","author":"Buddeberg","year":"2022","journal-title":"Front Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s11701-025-02358-6","volume":"19","author":"Xiaosong","year":"2025","journal-title":"J Robot Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115774","volume":"25","author":"Karol","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2020.07.053","volume":"82","author":"Gian Piero","year":"2020","journal-title":"Int J Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1039\/d4tb00483c","volume":"12","author":"Jianing","year":"2024","journal-title":"J Mater Chem B"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/jbi\/wbad064","volume":"5","author":"T","year":"2023","journal-title":"J Breast Imaging"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i9.2267","volume":"20","author":"Margaret","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"217119","DOI":"10.1016\/j.canlet.2024.217119","volume":"598","author":"Delahousse","year":"2024","journal-title":"Cancer Lett"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"Cd004064","DOI":"10.1002\/14651858.CD004064.pub4","volume":"8","author":"Wagner","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/jamp.2007.0656","volume":"21","author":"Gagnadoux","year":"2008","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.drup.2016.10.003","volume":"29","author":"Gabizon","year":"2016","journal-title":"Drug Resist Updat"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"3687700","DOI":"10.1155\/2021\/3687700","volume":"2021","author":"Sharifi-Rad","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1046\/j.1525-1438.2001.11(suppl.1)sup1021.x","volume":"11 Suppl 1","author":"Vermorken","year":"2001","journal-title":"Int J Gynecol Cancer"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"115323","DOI":"10.1016\/j.bcp.2022.115323","volume":"206","author":"Romani","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.rpor.2019.09.002","volume":"24","author":"Ratosa","year":"2019","journal-title":"Rep Pract Oncol Radiother"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1586\/era.12.126","volume":"12","author":"Hess","year":"2012","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1586\/14737140.2.3.297","volume":"2","author":"Cozzi","year":"2002","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00066-007-1631-3","volume":"183","author":"Guckenberger","year":"2007","journal-title":"Strahlenther Onkol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s11060-022-04101-9","volume":"159","author":"Imber","year":"2022","journal-title":"J Neurooncol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000328254","volume":"49","author":"Pe\u2019er","year":"2012","journal-title":"Dev Ophthalmol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1365-2710.2005.00655.x","volume":"30","author":"Singh Ranger","year":"2005","journal-title":"J Clin Pharm Ther"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2165\/00002018-199921040-00005","volume":"21","author":"Michaud","year":"1999","journal-title":"Drug Saf"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ejca.2004.07.035","volume":"41","author":"Robertson","year":"2005","journal-title":"Eur J Cancer"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1046\/j.1464-410x.2003.04026.x","volume":"91","author":"Anderson","year":"2003","journal-title":"BJU Int"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2165\/00002512-199101060-00008","volume":"1","author":"Chrisp","year":"1991","journal-title":"Drugs Aging"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1080\/03007995.2018.1447450","volume":"34","author":"Kassem","year":"2018","journal-title":"Curr Med Res Opin"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1517\/14728210902976842","volume":"14","author":"Homs","year":"2009","journal-title":"Expert Opin Emerg Drugs"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11523-012-0250-9","volume":"8","author":"Casaluce","year":"2013","journal-title":"Target Oncol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1345\/aph.1Q363","volume":"45","author":"Heakal","year":"2011","journal-title":"Ann Pharmacother"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/s0090-4295(02)01589-3","volume":"60","author":"George","year":"2002","journal-title":"Urology"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1080\/14656566.2016.1236914","volume":"17","author":"Martinello","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s11523-019-00680-2","volume":"14","author":"Sachdev","year":"2019","journal-title":"Target Oncol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.3389\/fimmu.2019.02856","volume":"10","author":"Deak","year":"2019","journal-title":"Front Immunol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2147\/bctt.S424624","volume":"15","author":"Anayyat","year":"2023","journal-title":"Breast Cancer"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.euo.2020.06.009","volume":"3","author":"Rouanne","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15225345","volume":"15","author":"Manna","year":"2023","journal-title":"Cancers"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25136969","volume":"25","author":"Chis","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"654","DOI":"10.21037\/gs-24-81","volume":"13","author":"Wang","year":"2024","journal-title":"Gland Surg"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"Cd013579","DOI":"10.1002\/14651858.CD013579.pub2","volume":"5","author":"McBain","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta17140","volume":"17","author":"Hoyle","year":"2013","journal-title":"Health Technol Assess"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.7150\/ijbs.34213","volume":"15","author":"Ma","year":"2019","journal-title":"Int J Biol Sci"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2021.100826","volume":"46","author":"Denlinger","year":"2022","journal-title":"Curr Probl Cancer"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12943-022-01663-0","volume":"21","author":"Lu","year":"2022","journal-title":"Mol Cancer"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005755","volume":"10","author":"Chesney","year":"2022","journal-title":"J Immunother Cancer"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s40291-024-00708-y","volume":"28","author":"Keam","year":"2024","journal-title":"Mol Diagn Ther"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/ajh.26301","volume":"96","author":"Westin","year":"2021","journal-title":"Am J Hematol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1053\/j.seminoncol.2019.07.002","volume":"46","author":"Alterio","year":"2019","journal-title":"Semin Oncol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00262-021-03013-3","volume":"71","author":"Behranvand","year":"2022","journal-title":"Cancer Immunol Immunother"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s12032-024-02517-z","volume":"41","author":"Joshi","year":"2024","journal-title":"Med Oncol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw5473","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010645","volume":"24","author":"De Novellis","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1158\/2159-8290.Cd-20-1638","volume":"11","author":"Aldea","year":"2021","journal-title":"Cancer Discov"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1344272","DOI":"10.3389\/fimmu.2024.1344272","volume":"15","author":"Ouyang","year":"2024","journal-title":"Front Immunol"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1002\/ijc.34453","volume":"152","author":"Ishihara","year":"2023","journal-title":"Int J Cancer"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147484","volume":"22","author":"Kim","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1172\/jci129204","volume":"130","author":"Vago","year":"2020","journal-title":"J Clin Invest"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/07357907.2021.2005798","volume":"40","author":"Zeng","year":"2022","journal-title":"Cancer Invest"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41586-023-05778-2","volume":"615","author":"Tousley","year":"2023","journal-title":"Nature"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"162","DOI":"10.2174\/187152009787313828","volume":"9","author":"Marin","year":"2009","journal-title":"Anticancer Agents Med Chem"},{"key":"ref72","unstructured":"SINO-CELL. Good news continues to emerge for FAST-TIL, building an overwhelming momentum in the fight against melanoma. Available from: https:\/\/www.sino-cellbiomed.com\/page19.html?article_id=1105. Accessed May 01, 2026."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.1158\/1078-0432.Ccr-21-4384","volume":"28","author":"Meister","year":"2022","journal-title":"Clin Cancer Res"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3389\/fonc.2012.00165","volume":"2","author":"Multhoff","year":"2012","journal-title":"Front Oncol"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41572-018-0055-y","volume":"5","author":"Achrol","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1517\/14712598.2015.1046430","volume":"15","author":"Chmielewski","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"131828","DOI":"10.1016\/j.ijbiomac.2024.131828","volume":"268","author":"Yang","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/bs.acr.2022.03.006","volume":"155","author":"Mauro","year":"2022","journal-title":"Adv Cancer Res"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-021-04390-6","volume":"602","author":"Melenhorst","year":"2022","journal-title":"Nature"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1182\/blood-2021-146045","volume":"138","author":"Lekakis","year":"2021","journal-title":"Blood"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1182\/blood.2024024523","volume":"144","author":"Nicolai","year":"2024","journal-title":"Blood"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12935-025-03938-0","volume":"25","author":"Zhu","year":"2025","journal-title":"Cancer Cell Int"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1182\/bloodadvances.2023011992","volume":"8","author":"Baguet","year":"2024","journal-title":"Blood Adv"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41577-021-00547-6","volume":"22","author":"Morris","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2022-0037","author":"Kamal-Bahl","year":"2022","journal-title":"Immunotherapy"},{"key":"ref86","unstructured":"Insights GM. Oncology Market \u2013 by Cancer Diagnostics and Treatment, By Cancer Type, By End Use\u2013 global Forecast, 2025 to 2034. Available from: https:\/\/www.gminsights.com\/industry-analysis\/oncology-market. Accessed May 01, 2026."},{"key":"ref87","unstructured":"insights Br. Immune Cell Therapy Drugs Market Size, Share, Growth, and Industry Analysis, By Type (Monoclonal Antibodies, Immunomodulator, and Other), By Application (Stomach Cancer, lung Cancer, Colorectal Cancer, Esophageal Cancer, Pancreatic Cancer, and Other), Regional Insights and Forecast From 2025 To 2033. Available from: https:\/\/www.businessresearchinsights.com\/market-reports\/immune-cell-therapy-drugs-market-113898. Accessed May 01, 2026."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/s1470-2045(21)00375-2","volume":"22","author":"Schuster","year":"2021","journal-title":"Lancet Oncol"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/s1470-2045(18)30864-7","volume":"20","author":"Locke","year":"2019","journal-title":"Lancet Oncol"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/s0140-6736(21)01222-8","volume":"398","author":"Shah","year":"2021","journal-title":"Lancet"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/s1470-2045(22)00339-4","volume":"23","author":"Sehgal","year":"2022","journal-title":"Lancet Oncol"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1038\/s41591-023-02496-0","volume":"29","author":"Lin","year":"2023","journal-title":"Nat Med"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/s0140-6736(21)00933-8","volume":"398","author":"Berdeja","year":"2021","journal-title":"Lancet"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2406526","volume":"391","author":"Roddie","year":"2024","journal-title":"N Engl J Med"},{"key":"ref95","unstructured":"News e. 100% ORR and 100% DCR were achieved in the first dual-targeted KD-496 CAR-T IIT clinical study, demonstrating breakthrough efficacy. 2025. Available from: https:\/\/mp.weixin.qq.com\/s\/FCG9Mfi1IIqERqAVZMo83w?mpshare=1&srcid=0427ilcPZEipIddNyVztxZSm&sharer_shareinfo=5912bfd985e56dad4bca92722fb6ac30&sharer_shareinfo_first=5912bfd985e56dad4bca92722fb6ac30&from=industrynews&scene=1&subscene=10000&sessionid=1745745618&clicktime=1745745623&enterid=1745745623&ascene=1&fasttmpl_type=0&fasttmpl_fullversion=7704844-zh_CN-zip&fasttmpl_flag=0&realreporttime=1745745623617&devicetype=android-35&version=28003a35&nettype=3gnet&lang=zh_CN&countrycode=CN&exportkey=n_ChQIAhIQgJbVaQbsLyk2rOMPXfmgThL2AQIE97dBBAEAAAAAAK1kI1MD+VsAAAAOpnltbLcz9gKNyK89dVj0yjBQtgezIBfAkGxigrNdszgc6XqN\/7BFH1gK9lHxGd27v+znq6sH9W54727M0GLEiqHYT8I7r\/KrOq9hSu3Xr2dLrv1+H+VB4tuebtCfJ3zgeF4SPpV5Lvxfm1QBTrdOgELCnqh9uMTT7uilAZUDAmt\/2qxe9l9Kjwc3x+QZ7ftL0vYKFaVhJTrYliJHiOJFk\/c9zca5yvVLCU8kpCTV8KmlwSi0f+Wdv\/ovM5\/om9NRhPRAeXwShT+evewaqtzulXF3\/o3TywxoolP\/AF1Vbg==&pass_ticket=XAfWoZYSaf6YT5kskNCT+z\/BTmY64N6EVOZGrwh72vV9lIBRkMHd0sFdV0IIZrKC&wx_header=3&color_scheme=light. Accessed May 01, 2026."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1200\/JCO.2024.42.16_suppl.2548","volume":"42","author":"Qin","year":"2024","journal-title":"J Clin Oncol"},{"key":"ref97","unstructured":"Therapeutics J. The pivotal Phase II clinical trial has been approved. Juncell\u2019s GC101 TIL therapy demonstrates enhanced safety and efficacy compared to existing treatments. Available from: https:\/\/www.juncell.com\/company-news-100. Accessed May 01, 2026."},{"key":"ref98","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1200\/jco.21.01805","volume":"40","author":"Carvajal","year":"2022","journal-title":"J Clin Oncol"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/s0140-6736(24)00319-2","volume":"403","author":"D\u2019Angelo","year":"2024","journal-title":"Lancet"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1007\/s12072-021-10250-2","volume":"15","author":"Meng","year":"2021","journal-title":"Hepatol Int"},{"key":"ref101","unstructured":"NEWSWIRE G. IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AML. Available from: https:\/\/www.nasdaq.com\/press-release\/in8bio-presents-positive-phase-1-data-tct-2025-highlighting-durability-remissions. Accessed May 01, 2026."},{"key":"ref102","doi-asserted-by":"publisher","first-page":"S407","DOI":"10.1016\/j.annonc.2024.08.512","volume":"35","author":"Li","year":"2024","journal-title":"Ann Oncol"},{"key":"ref103","unstructured":"Jiao Y. Ruishun Bio: the first allogeneic DNT cell drug for the treatment of relapsed\/refractory acute myeloid leukemia in China has been approved for clinical trials. Available from: https:\/\/mp.weixin.qq.com\/s?src=11\u00d7tamp=1747101892&ver=5987&signature=BbgypsGN-ZJk3so2qjWFhUIGMhgZbELPLMAz2h8624jWnC*RNxTrrNMIvakkR3zaju6xC797stmIo1ThLqFe*txjxt83wewDVruHYCrKJqJdSt1UxvtrVU-QG6Wpiea-&new=1. Accessed May 01, 2026."},{"key":"ref104","unstructured":"therapy Cag. During the ASCO conference, NK-Celltech presented the clinical data for the allogeneic peripheral blood-derived NK010 injection. Available from: https:\/\/www.oneyao.com\/newsDetail\/a2bbd02d5c265217555cae4af2df6239021b1c0b\/. Accessed May 01, 2026."},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174229","volume":"14","author":"Leem","year":"2022","journal-title":"Cancers"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1200\/JCO.2022.40.16_suppl.2533","volume":"40","author":"Reiss","year":"2022","journal-title":"J Clin Oncol"},{"key":"ref107","unstructured":"Cri. CRI Regulatory Approval Timeline of Active Immunotherapies. Available from: https:\/\/www.cancerresearch.org\/regulatory-approval-timeline-of-active-immunotherapies. Accessed May 01, 2026."},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph191912366","volume":"19","author":"Choi","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.tibtech.2024.09.013","volume":"43","author":"Chen","year":"2025","journal-title":"Trends Biotechnol"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12913-023-10443-5","volume":"24","author":"Cavallo","year":"2024","journal-title":"BMC Health Serv Res"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.ccell.2025.03.019","volume":"43","author":"Du","year":"2025","journal-title":"Cancer Cell"},{"key":"ref112","unstructured":"Henshall GMATSDPBDC. Gene therapy: understanding the science, assessing the evidence, and paying for value. Office of Health Economics. 2017."},{"key":"ref113","doi-asserted-by":"publisher","first-page":"101358","DOI":"10.1016\/j.blre.2025.101358","author":"Kaparis","year":"2025","journal-title":"Blood Rev"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13643-017-0517-4","volume":"6","author":"Pettitt","year":"2017","journal-title":"Syst Rev"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13045-024-01530-z","volume":"17","author":"Xu","year":"2024","journal-title":"J Hematol Oncol"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1186\/s12913-021-07196-4","volume":"21","author":"Medlinskiene","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"ref117","unstructured":"BIOMED S-C. CLINICAL TRIALS. Available from: https:\/\/www.sino-cellbiomed.com\/page18.html. Accessed May 01, 2026."},{"key":"ref118","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1158\/1078-0432.Ccr-21-4097","volume":"28","author":"Zhang","year":"2022","journal-title":"Clin Cancer Res"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100348","volume":"2","author":"Venkatesan","year":"2021","journal-title":"Cell Rep Med"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"1237704","DOI":"10.3389\/frai.2023.1237704","volume":"6","author":"Chakraborty","year":"2023","journal-title":"Front Artif Intell"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"1715536","DOI":"10.1080\/20016689.2020.1715536","volume":"8","author":"J\u00f8rgensen","year":"2020","journal-title":"J Market Access Health Policy"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"8543","DOI":"10.34172\/ijhpm.8543","volume":"13","author":"Zheng","year":"2024","journal-title":"Int J Health Policy Manag"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2217\/rme-2016-0014","volume":"11","author":"Malik","year":"2016","journal-title":"Regener Med"},{"key":"ref124","unstructured":"TABotHBLIMTPZatMaDR A. Notice on Printing and Distributing the Implementation Catalogue for the Transformation and Application of New Biomedical Technologies in the Hainan Boao Lecheng International Medical Tourism Pilot Zone. Available from: https:\/\/zhuanlan.zhihu.com\/p\/29624262462. Accessed May 01, 2026."},{"key":"ref125","doi-asserted-by":"publisher","first-page":"e59954","DOI":"10.7759\/cureus.59954","volume":"16","author":"Dixon","year":"2024","journal-title":"Cureus"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cell.2020.03.001","volume":"181","author":"Weber","year":"2020","journal-title":"Cell"},{"key":"ref127","volume-title":"Accessing Cell and Gene Therapies: Insights on Coverage, Reimbursement and Emerging Models","year":"2023"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"m3434","DOI":"10.1136\/bmj.m3434","volume":"371","author":"Hwang","year":"2020","journal-title":"BMJ"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1080\/13696998.2024.2346406","volume":"27","author":"Zhang","year":"2024","journal-title":"J Med Econ"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/14737167.2024.2339945","volume":"24","author":"Hiligsmann","year":"2024","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"ref131","unstructured":"C--bw SANTAMONICA. Yescarta\u00ae Is First CAR T-cell Therapy to Report Five-Year Survival Data From Pivotal Study Showing Durable Long-Term Survival in Patients With Refractory Large B-cell Lymphoma. Available from: https:\/\/www.gilead.com\/news\/news-details\/2021\/yescarta-is-first-car-t-cell-therapy-to-report-five-year-survival-data-from-pivotal-study-showing-durable-long-term-survival-in-patients-with-refractory-large-b-cell-lymphoma. Accessed May 01, 2026."},{"key":"ref132","unstructured":"reporter Ed. TILs confirm to prolong PFS compared with immunotherapy in advanced melanoma. Immunotherapy. Available from: https:\/\/dailyreporter.esmo.org\/esmo-congress-2022\/research-advances-in-the-last-months\/tils-confirm-to-prolong-pfs-compared-with-immunotherapy-in-advanced-melanoma. Accessed May 01, 2026."},{"key":"ref133","doi-asserted-by":"publisher","first-page":"e397912","DOI":"10.1200\/edbk_397912","author":"Cliff","year":"2023","journal-title":"Am Soc Clin Oncol Educat Book"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1177\/2168479018779373","volume":"53","author":"Vaggelas","year":"2019","journal-title":"Ther Innov Regul Sci"},{"key":"ref135","unstructured":"Association AM. How to Develop an Effective Marketing Strategy: a Step-by-Step Guide to Strategic Marketing Planning. Available from: https:\/\/www.ama.org\/marketing-news\/how-to-develop-an-effective-marketing-strategy\/. Accessed May 01, 2026."},{"key":"ref136","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/br.2017.922","volume":"7","author":"Mathur","year":"2017","journal-title":"Biomed Rep"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"9585614","DOI":"10.1155\/2018\/9585614","volume":"2018","author":"Koury","year":"2018","journal-title":"J Immunol Res"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/j.jcyt.2025.03.070","volume":"27","author":"Pasa","year":"2025","journal-title":"Cytotherapy"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11899-023-00687-7","volume":"18","author":"Chohan","year":"2023","journal-title":"Curr Hematol Malig Rep"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41409-024-02504-y","volume":"60","author":"Boyer","year":"2025","journal-title":"Bone Marrow Transplant"}],"container-title":["Cancer Management and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/114866","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/114866","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:11:15Z","timestamp":1777993875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/customized-marketing-strategies-for-cancer-immunocyte-therapy-based-on-peer-reviewed-fulltext-article-CMAR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":140,"URL":"https:\/\/doi.org\/10.2147\/cmar.s604924","relation":{},"ISSN":["1179-1322"],"issn-type":[{"value":"1179-1322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}